Saini Aayushi, Mehrotra Seema, Solanki Vandana, Verma Manju Lata, Shankhwar Pushp Lata, Jaiswar S P
Department of Obstetrics and Gynaecology, King George's Medical University, Lucknow, India.
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):466-472. doi: 10.1007/s13224-024-02084-3. Epub 2024 Nov 26.
Ultrasound has an important role in in pregnancy complicated by hyperglycaemia. This study is to assess the association between third trimester ultrasound parameters and adverse outcomes in hyperglycaemic pregnant women & neonates.
A prospective observational study including 166 hyperglycemic pregnant women (39-preexisting; 127-GDM) Ultrasound was done between 34 weeks gestation and beyond to note parameters i.e. FW centile, AC centile, CPR ratio, AFI. All were followed till delivery; adverse outcomes noted (C-section done for fetal distress, arterial cord blood ph < 7.1, 5 min APGAR < 7, admission to neonatal unit, neonatal hypoglycemia, perinatal death). Composite adverse outcomes were determined by having any 2/7 above-described outcomes. Ultrasound parameters were then correlated with composite adverse outcomes and correlation was determined.
Out of 166; in 66 pregnancies composite adverse neonatal outcomes were present. Women with HIP having > 90th centile of estimated fetal weight have 3.52 times higher chances [OR 3.52 & 95% CI (1.55-7.97)] of having CAO compared to rest of the women. Statistically, a significant association was found for Composite Adverse Outcomes and deranged AFI ( value < 0.018). Women with HIP having Polyhydramnios have 3.13 times higher odds [OR 3.13 & 95% CI (1.08-8.94)] of having CAO compared to rest of the women. Further, Women with HIP having cerebroplacental insufficiency i.e. CPR < 1 have 4.2 times higher odds [OR 4.200 (CI 1.825-9.668)] of having CAO compared to rest of the women with HIP i.e. women having CPR > 1.
In women with hyperglycemia, third trimester USG parameters have an important role in predicting adverse outcomes beyond the impact of maternal predictors. The best combination of USG parameters detecting Composite Adverse Outcomes was EFW < 10th centile and CPR < 1 (OR 14.61). So third trimester sonographic parameters appears to be promising tool to preplan deliveries that should be conducted in tertiary care centres to reduce perinatal morbidity and mortality.
超声在妊娠合并高血糖中具有重要作用。本研究旨在评估孕晚期超声参数与高血糖孕妇及新生儿不良结局之间的关联。
一项前瞻性观察性研究,纳入166例高血糖孕妇(39例为孕前糖尿病;127例为妊娠期糖尿病)。在妊娠34周及以后进行超声检查,记录胎儿体重百分位数(FW centile)、腹围百分位数(AC centile)、脑胎盘率(CPR ratio)、羊水指数(AFI)等参数。所有孕妇随访至分娩,记录不良结局(因胎儿窘迫行剖宫产、脐动脉血pH值<7.1、5分钟阿氏评分<7、入住新生儿病房、新生儿低血糖、围产期死亡)。复合不良结局由上述7项结局中的任意2项确定。然后将超声参数与复合不良结局进行相关性分析并确定相关性。
166例孕妇中,66例出现复合不良新生儿结局。估计胎儿体重百分位数>90的孕前糖尿病孕妇发生复合不良结局的几率是其他孕妇的3.52倍[比值比(OR)3.52,95%置信区间(CI)(1.55 - 7.97)]。统计学上,复合不良结局与羊水指数异常(值<0.018)之间存在显著关联。羊水过多的孕前糖尿病孕妇发生复合不良结局的几率是其他孕妇的3.13倍[OR 3.13,95% CI(1.08 - 8.94)]。此外,脑胎盘功能不全即CPR<1的孕前糖尿病孕妇发生复合不良结局的几率是CPR>1的其他孕前糖尿病孕妇的4.2倍[OR 4.200(CI 1.825 - 9.668)]。
对于高血糖孕妇,孕晚期超声参数在预测不良结局方面具有重要作用,其作用超过母体预测因素的影响。检测复合不良结局的最佳超声参数组合是胎儿体重百分位数<10且CPR<1(OR 14.61)。因此,孕晚期超声参数似乎是一种有前景的工具,可用于在三级医疗中心预先规划分娩,以降低围产期发病率和死亡率。